COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 2273: Articles 22721-22730  | Next

Neighborhood-Level Public Facilities and COVID-19 Transmission: A Nationwide Geospatial Study In China
Jin, X., Leng, Y., Gong, E., Xiong, S., Yao, Y., Vedanthan, R., Wu, C., Yan, L. L.
10.1101/2020.08.25.20181362 — Posted: 2020-08-31
Twitter Interaction to Analyze Covid-19 Impact in Ghana, Africa from March to July
Chire Saire, J. E., Panford-Quainoo, K.
10.1101/2020.08.25.20182048 — Posted: 2020-08-31
Phosphate levels and pulmonary damage in COVID-19 patients based on CO-RADS scheme: is there any link between parathyroid gland and COVID-19?
Javdani, F., Parsa, S., Shakeri, H., Hatami, N., Kalani, N., Haghbeen, M., Raufi, R., Abbasi, A., Keshavarz, P., Hashemi, S. A., shafiee, A.
10.1101/2020.08.25.20181453 — Posted: 2020-08-31
A comparison of Emergency Department presentations for Medically Unexplained Symptoms in Frequent Attenders during COVID-19
Daniels, N. F., Ridwan, R., Barnard, E. B., Amanullah, T. M., Hayhurst, C.
10.1101/2020.08.25.20181511 — Posted: 2020-08-31
Diagnosis of COVID-19 from X-rays Using Combined CNN-RNN Architecture with Transfer Learning
Islam, M. M., Islam, M. Z., Asraf, A., Ding, W.
10.1101/2020.08.24.20181339 — Posted: 2020-08-31
Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic
Li, G., Shivam, S., Hochberg, M. E., Wardi, Y., Weitz, J. S.
10.1101/2020.08.24.20180752 — Posted: 2020-08-31
Correction of Daily Positivity Rates for contribution of various test protocols being used in a pandemic.
Bansal, B.
10.1101/2020.08.25.20181347 — Posted: 2020-08-31
Stability of SARS-CoV-2 on surfaces
Kwon, T., Gaudreault, N. N., Richt, J. A.
10.1101/2020.08.30.274241 — Posted: 2020-08-30
SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function
Marchiano, S., Hsiang, T.-Y., Higashi, T., Kanna, A., Reinecke, H., Yang, X., Pabon, L., Sniadecki, N. J., Bertero, A., Gale, M., Murry, C. E.
10.1101/2020.08.30.274464 — Posted: 2020-08-30 Discussion: Onsite
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., Robbiani, D. F., Nussenzweig, M. C., West, A. P., Bjorkman, P. J.
10.1101/2020.08.30.273920 — Posted: 2020-08-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).